Latest Partnerships News

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.

Nordic Resources has expanded its Kopsa gold-copper project in Finland through an upsized drilling program, confirming significant new mineralised zones and securing over A$10 million in institutional funding.

Cyprium Metals is advancing its brownfield restart of the Nifty Copper Complex in Western Australia, targeting mid-2026 copper cathode production with a low-capital, high-cash-flow approach. The company has secured $41 million through an institutional placement and entitlement offer to fund exploration and expansion.

Codeifai Limited has raised $1.1 million through a share placement to fund the commercialisation of a quantum-secured platform and broaden its AI capabilities into new industrial sectors.

Peak Processing has significantly expanded its manufacturing partnership with St. Peter’s Beverages, tripling its SKU production and boosting annual output by up to 700,000 units. This move strengthens its foothold in North America’s cannabis beverage market using proprietary technology.

Pure Foods Tasmania has launched contract manufacturing with Brilliant Food Australia, marking a significant step in utilising its Woodbridge Smokehouse facility and expanding regional employment.

Visionflex Group’s Q2 FY26 report reveals a 23% rise in annual recurring revenue and improved cash flow, even as overall revenue slips due to lower hardware sales.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Accelerate Resources has advanced its gold exploration at Balagundi and manganese prospects in Pilbara, bolstered by a $900,000 capital raise and a strategic joint venture at the Comet Gold Project.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.